Bairong Xia

2.8k total citations
73 papers, 1.8k citations indexed

About

Bairong Xia is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Bairong Xia has authored 73 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 23 papers in Cancer Research and 20 papers in Oncology. Recurrent topics in Bairong Xia's work include Ovarian cancer diagnosis and treatment (15 papers), Cancer-related molecular mechanisms research (12 papers) and Endometrial and Cervical Cancer Treatments (8 papers). Bairong Xia is often cited by papers focused on Ovarian cancer diagnosis and treatment (15 papers), Cancer-related molecular mechanisms research (12 papers) and Endometrial and Cervical Cancer Treatments (8 papers). Bairong Xia collaborates with scholars based in China and Pakistan. Bairong Xia's co-authors include Weilin Jin, Ge Lou, Chang Yang, Tianbo Liu, Ge Lou, Shanshan Yang, Ge Lou, Mingzhu Jin, Yongjian Zhang and Mei Lin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Bairong Xia

66 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bairong Xia China	26	1.1k	861	410	216	187	73	1.8k
Yuexin Liu China	16	872 0.8×	659 0.8×	401 1.0×	121 0.6×	210 1.1×	56	1.5k
Lisha Qi China	28	1.4k 1.3×	893 1.0×	585 1.4×	201 0.9×	415 2.2×	71	2.4k
Hao Wen China	26	981 0.9×	517 0.6×	453 1.1×	189 0.9×	274 1.5×	103	2.1k
S. John Weroha United States	21	741 0.7×	368 0.4×	610 1.5×	107 0.5×	174 0.9×	71	1.5k
Wei Xiao China	25	1.2k 1.1×	968 1.1×	383 0.9×	147 0.7×	231 1.2×	44	1.9k
Nayiyuan Wu China	24	1.7k 1.6×	1.1k 1.3×	742 1.8×	426 2.0×	557 3.0×	84	2.9k
Ardeshir Hakam United States	21	754 0.7×	573 0.7×	374 0.9×	69 0.3×	157 0.8×	54	1.4k
Nameer B. Kirma United States	22	593 0.5×	286 0.3×	402 1.0×	274 1.3×	128 0.7×	63	1.4k
Giorgio Giurato Italy	25	1.8k 1.6×	999 1.2×	301 0.7×	189 0.9×	106 0.6×	88	2.3k

Countries citing papers authored by Bairong Xia

Since Specialization

Citations

This map shows the geographic impact of Bairong Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bairong Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bairong Xia more than expected).

Fields of papers citing papers by Bairong Xia

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bairong Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bairong Xia. The network helps show where Bairong Xia may publish in the future.

Co-authorship network of co-authors of Bairong Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Bairong Xia. A scholar is included among the top collaborators of Bairong Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bairong Xia. Bairong Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Ping, Bairong Xia, Yuan Lei, et al.. (2025). Gut microbiota dysbiosis amplifies thiram hepatotoxicity via a mitochondrial-autophagy-apoptosis nexus orchestrated by the gut-liver axis. Cellular Signalling. 136. 112104–112104. 4 indexed citations

Qin, Yang, Jiaqi Wang, Bo Huang, et al.. (2025). A Pectin-Based Delivery Nanoplatform with an Optimized Tradeoff between Active Targeting and Drug Loading for Hepatocellular Carcinoma Treatment. Molecular Pharmaceutics. 22(9). 5555–5566.

Chen, Wei‐Min, et al.. (2024). Feasibility and safety of transvaginal natural orifice transluminal endoscopic surgery (V-NOTES) panhysterectomy: a polycentric retrospective study. European journal of medical research. 29(1). 605–605. 1 indexed citations

Tang, Huimin, et al.. (2023). Mature cystic extragonadal teratoma in Douglas’ pouch: Case report and literature review. Frontiers in Medicine. 9. 985235–985235. 1 indexed citations

Shen, Yuanming, Beihua Kong, Bairong Xia, et al.. (2023). Pegylated liposomal doxorubicin and carboplatin versus paclitaxel and carboplatin as first-line treatment for Chinese patients with ovarian cancer: A multi-center, randomized, open-label trial.. Journal of Clinical Oncology. 41(16_suppl). 5556–5556. 1 indexed citations

Sun, Lei, et al.. (2023). The PAPSS1 gene is a modulator of response to cisplatin by regulating estrogen receptor alpha signaling activity in ovarian cancer cells. Journal of Ovarian Research. 16(1). 187–187. 3 indexed citations

Zhang, Shoufeng, et al.. (2022). Preliminary Analysis of Safety and Feasibility of a Single-Hole Laparoscopic Myomectomy via an Abdominal Scar Approach. Frontiers in Surgery. 9. 916792–916792.

Chen, Yu, et al.. (2021). The role of CEMIP in tumors: An update based on cellular and molecular insights. Biomedicine & Pharmacotherapy. 146. 112504–112504. 14 indexed citations

Xie, Hongyu, et al.. (2021). Targeting DNA Repair Response Promotes Immunotherapy in Ovarian Cancer: Rationale and Clinical Application. Frontiers in Immunology. 12. 661115–661115. 11 indexed citations

10.

Wang, Wenjie, Hongyu Xie, Bairong Xia, et al.. (2021). Identifying Potential Markers for Monitoring Progression to Ovarian Cancer Using Plasma Label-free Proteomics. Journal of Cancer. 12(6). 1651–1659. 6 indexed citations

11.

Cao, Lei, Jinying Yang, Zhiwei Rong, et al.. (2021). A novel attention-guided convolutional network for the detection of abnormal cervical cells in cervical cancer screening. Medical Image Analysis. 73. 102197–102197. 69 indexed citations

12.

Chen, Yu, Lin Hao, Yanan Pi, et al.. (2021). Development and Validation of a Prognostic Signature Based on Immune Genes in Cervical Cancer. Frontiers in Oncology. 11. 616530–616530. 7 indexed citations

13.

Pi, Yanan, Bairong Xia, Mingzhu Jin, Weilin Jin, & Ge Lou. (2021). Exosomes: Powerful weapon for cancer nano-immunoengineering. Biochemical Pharmacology. 186. 114487–114487. 30 indexed citations

14.

Yang, Chang, et al.. (2020). Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant. Frontiers in Immunology. 11. 577869–577869. 222 indexed citations

15.

Xie, Hongyu, Wenjie Wang, Bairong Xia, Weilin Jin, & Ge Lou. (2020). Therapeutic applications of PARP inhibitors in ovarian cancer. Biomedicine & Pharmacotherapy. 127. 110204–110204. 29 indexed citations

16.

Jin, Mingzhu, et al.. (2019). Long Non-coding RNA DANCR as an Emerging Therapeutic Target in Human Cancers. Frontiers in Oncology. 9. 1225–1225. 55 indexed citations

17.

Xia, Bairong, Mei Lin, Wei Dong, et al.. (2018). Upregulation of miR‐874‐3p and miR‐874‐5p inhibits epithelial ovarian cancer malignancy via SIK2. Journal of Biochemical and Molecular Toxicology. 32(8). e22168–e22168. 43 indexed citations

18.

Jin, Mingzhu, Bairong Xia, Yu Xu, & Weilin Jin. (2018). Curaxin CBL0137 Exerts Anticancer Activity via Diverse Mechanisms. Frontiers in Oncology. 8. 598–598. 29 indexed citations

19.

Kong, Dan, Jing Li, Bairong Xia, et al.. (2015). The effect of SCF and ouabain on small intestinal motility dysfunction induced by gastric cancer peritoneal metastasis. Clinical & Experimental Metastasis. 32(3). 267–277. 10 indexed citations

20.

Lin, Mei, et al.. (2012). Anti-ovarian cancer potential of two acidic polysaccharides from the rhizoma of Menispermum dauricum. Carbohydrate Polymers. 92(2). 2212–2217. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact